Mario C Rico
Overview
Explore the profile of Mario C Rico including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou J, Rico M, Rauova L, Poncz M, Essex D
Res Pract Thromb Haemost
. 2024 Jul;
8(4):102472.
PMID: 39036672
Background: Five secreted platelet protein disulfide isomerases (PDIs) and 1 transmembrane PDI regulate platelet function and thrombosis. Thioredoxin-related transmembrane protein 1 (TMX1) was the first member of the PDI family...
2.
Rico M, Perez-Leal O, Barbe M, Amin M, Colussi D, Florez M, et al.
Biomolecules
. 2023 Sep;
13(9).
PMID: 37759735
Extracellular histones, part of the protein group known as damage-associated molecular patterns (DAMPs), are released from damaged or dying cells and can instigate cellular toxicity. Within the context of chronic...
3.
Quinn C, Rico M, Merali C, Barrero C, Perez-Leal O, Mischley V, et al.
Sci Transl Med
. 2023 Sep;
15(715):eade2966.
PMID: 37756380
Hepatic fibrosis is the primary determinant of mortality in patients with metabolic dysfunction-associated steatohepatitis (MASH). Transforming growth factor-β (TGFβ), a master profibrogenic cytokine, is a promising therapeutic target that has...
4.
Quinn C, Rico M, Merali C, Merali S
Int J Mol Sci
. 2022 Feb;
23(4).
PMID: 35216100
Nonalcoholic fatty liver disease (NAFLD) is the number one cause of chronic liver disease worldwide, with 25% of these patients developing nonalcoholic steatohepatitis (NASH). NASH significantly increases the risk of...
5.
Perez-Leal O, Nixon-Abell J, Barrero C, Gordon J, Oesterling J, Rico M
CRISPR J
. 2021 Dec;
4(6):854-871.
PMID: 34847745
The lack of efficient tools to label multiple endogenous targets in cell lines without staining or fixation has limited our ability to track physiological and pathological changes in cells over...
6.
Al-Ashmawy A, Ragab F, Elokely K, Anwar M, Perez-Leal O, Rico M, et al.
Bioorg Med Chem Lett
. 2017 Jun;
27(14):3117-3122.
PMID: 28571824
PI3Kα/mTOR ATP-competitive inhibitors are considered as one of the promising molecularly targeted cancer therapeutics. Based on lead compound A from the literature, two similar series of 2-substituted-4-morpholino-pyrido[3,2-d]pyrimidine and pyrido[2,3-d]pyrimidine analogs...
7.
Liverani E, Rico M, Tsygankov A, Kilpatrick L, Kunapuli S
Arterioscler Thromb Vasc Biol
. 2016 Apr;
36(5):961-71.
PMID: 27055904
Objective: Platelets modulate hemostasis and immune responses via interactions with immune cells through secretion of immunemodulators and cell-cell interactions. The P2Y12 receptor mediates ADP-induced aggregation and secretion in platelets. Approach...
8.
Fisher P, Zhao Y, Rico M, Massicotte V, Wade C, Litvin J, et al.
J Cell Commun Signal
. 2015 Jan;
9(1):37-54.
PMID: 25617052
Key clinical features of cumulative trauma disorders include pain, muscle weakness, and tissue fibrosis, although the etiology is still under investigation. Here, we characterized the temporal pattern of altered sensorimotor...
9.
Liverani E, Rico M, Yaratha L, Tsygankov A, Kilpatrick L, Kunapuli S
J Leukoc Biol
. 2013 Oct;
95(2):313-23.
PMID: 24142066
Thienopyridines are a class of antiplatelet drugs that are metabolized in the liver to several metabolites, of which only one active metabolite can irreversibly antagonize the platelet P2Y12 receptor. Possible...
10.
Igbre A, Rico M, Garg S
Retina
. 2013 Aug;
34(3):504-8.
PMID: 23945636
Purpose: To evaluate the high-speed anterior segment optical coherence tomography (AS-OCT) grading of the AS inflammation in patients with ocular inflammation. Methods: A retrospective consecutive case series study. Patients with...